FX.co ★ Karyopharm Therapeutics Appoints Lori Macomber As CFO

Karyopharm Therapeutics Inc. (KPTI), a company dedicated to developing innovative cancer treatments, announced on Thursday the appointment of Lori Macomber as Chief Financial Officer, effective January 3. Macomber brings more than two decades of diverse experience to the role, having most recently served as the CFO of Legend Biotech Corporation. Her career includes significant leadership positions at Ametek PDS, Cello Health, Eli Lilly and Company, and Pfizer.